Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug4508 | Triazolam 0.25 MG Oral Tablet Wiki | 1.00 |
drug5171 | questionnaire assesment Wiki | 0.45 |
drug3273 | Placebo oral tablet Wiki | 0.17 |
Name (Synonyms) | Correlation | |
---|---|---|
D003095 | Collagen Diseases NIH | 0.33 |
D012216 | Rheumatic Diseases NIH | 0.30 |
D059350 | Chronic Pain NIH | 0.27 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0012532 | Chronic pain HPO | 0.27 |
HP:0001370 | Rheumatoid arthritis HPO | 0.26 |
HP:0001369 | Arthritis HPO | 0.22 |
Navigate: Correlations HPO
There is one clinical trial.
New technologies are needed to help diagnose anxiety disorders. EVestG has facilitated the identification of numerous possible biomarkers of several psychiatric disorders. Some EVestG features seem to be caused by differences in low-frequency modulation that is consistent (both in frequency and behaviour) with the hippocampal rhythm (theta), which is known to play a role in anxiety. Critically, there is ample support in the literature for an anatomical and functional basis for the modulation of vestibular signals via theta. If anxiety could be measured continuously, perhaps throughout a patient's day, or throughout a task, it might be able to confirm an anxiety disorder. However, current techniques for measuring theta are highly invasive, performed rarely, and only in epilepsy patients. EVestG technology, however, is non-invasive, and could potentially record anxiety levels in any subject for extended periods of time. The proposed study will attempt to identify hippocampal theta in vestibular signals in healthy participants through a double-blind administration of two different drugs that are dissimilar both pharmacologically and in acute clinical effects but which are known to reduce the theta rhythm.
Description: 4-12 Hz EEG power spectrum at F8 (10/20 international system) and in outer ear canal.
Measure: EEG power spectrum Time: Derived from EEGs recorded for 30-45 minsDescription: 4-12 Hz modulation of field potentials recorded in outer ear canal.
Measure: 4-12 Hz modulation Time: Derived from EEGs recorded for 30-45 mins.Description: 4-12 Hz correlations between F8 (10/20 international system) and outer ear canal activity.
Measure: Signal correlations Time: Derived from EEGs recorded for 30-45 minsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports